ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980